Hairy Cell Leukemia

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)

Active, not recruiting
  • Hairy Cell Leukemia
  • Moxetumomab Pasudotox-tdfk
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

Recruiting
  • Hairy Cell Leukemia
  • Hairy Cell Leukemia Variant
  • CD22CART cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

Active, not recruiting
  • Hairy Cell Leukemia
  • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2022

Hairy Cell Leukemia Trial in Poland, United States (Moxetumomab Pasudotox (CAT 8015), CAT 8015 (Moxetumomab Pasudotox))

Completed
  • Hairy Cell Leukemia
  • Moxetumomab Pasudotox (CAT 8015)
  • CAT 8015 (Moxetumomab Pasudotox)
  • Stanford, California
  • +3 more
Jan 2, 2019

Collecting and Storing Malignant, Borderline Malignant

Completed
  • Acute Undifferentiated Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +191 more
Jul 17, 2018

Hairy Cell Leukemia Trial run by the NCI (BL22 (CAT-3888))

Terminated
  • Hairy Cell Leukemia
  • BL22 (CAT-3888)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 7, 2015

Hairy Cell Leukemia Trial run by the NCI (Roferon-A)

Completed
  • Hairy Cell Leukemia
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008

Leukemia, Hairy Cell Leukemia, HCL Trial in Poland, United Kingdom, United States (Immunotoxin therapy, CAT-8015 Immunotoxin,

Unknown status
  • Leukemia
  • +2 more
  • Immunotoxin therapy
  • +2 more
  • Stanford, California
  • +4 more
Apr 16, 2007